Genotyping the risk of anthracycline-induced cardiotoxicity

ISSN： 1530-7905

Source： Cardiovascular Toxicology, Vol.7, Iss.2, 2007-06, pp. : 129-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anthracycline-Induced Cardiotoxicity

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 4, 2008-10 ,pp. : 278-281

Bentham Science Publishers

Access to resources Recommend Favorite

New iron chelators in anthracycline-induced cardiotoxicity

By Kaiserová Helena Šimůnek Tomáš Štěrba Martin Hartog Gertjan Schröterová Ladislava Popelová Olga Geršl Vladimír Kvasničková Eva Bast Aalt

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 145-150

Humana Press, Inc

Access to resources Recommend Favorite

Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults

By Dodos Fotiní

Clinical Research in Cardiology, Vol. 97, Iss. 5, 2008-05 ,pp. : 318-326

Springer Publishing Company

Access to resources Recommend Favorite

Anthracycline-induced phospholipase A₂ inhibition

By Swift Luther McHowat Jane Sarvazyan Narine

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 86-91

Humana Press, Inc

Access to resources Recommend Favorite

Novel antioxidants in anthracycline cardiotoxicity

By Hideg Kálmán Kálai Tamás

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 160-164

Humana Press, Inc

Access to resources Recommend Favorite